Progenics Pharmaceuticals Inc. EPS - Earnings per Share 2010-2020 | PGNX
Progenics Pharmaceuticals Inc. eps - earnings per share from 2010 to 2020. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Progenics Pharmaceuticals Inc. Annual EPS |
| 2019 |
$-0.80 |
| 2018 |
$-0.87 |
| 2017 |
$-0.73 |
| 2016 |
$0.15 |
| 2015 |
$-0.56 |
| 2014 |
$0.06 |
| 2013 |
$-0.76 |
| 2012 |
$-1.02 |
| 2011 |
$0.31 |
| 2010 |
$-2.14 |
| 2009 |
$-0.98 |
| Progenics Pharmaceuticals Inc. Quarterly EPS |
| 2020-03-31 |
$-0.19 |
| 2019-12-31 |
$-0.13 |
| 2019-09-30 |
$-0.22 |
| 2019-06-30 |
$-0.23 |
| 2019-03-31 |
$-0.22 |
| 2018-12-31 |
$-0.18 |
| 2018-09-30 |
$-0.30 |
| 2018-06-30 |
$-0.20 |
| 2018-03-31 |
$-0.19 |
| 2017-12-31 |
$-0.04 |
| 2017-09-30 |
$-0.22 |
| 2017-06-30 |
$-0.24 |
| 2017-03-31 |
$-0.23 |
| 2016-12-31 |
$-0.11 |
| 2016-09-30 |
$0.52 |
| 2016-06-30 |
$-0.08 |
| 2016-03-31 |
$-0.18 |
| 2015-12-31 |
$-0.10 |
| 2015-09-30 |
$-0.14 |
| 2015-06-30 |
$-0.17 |
| 2015-03-31 |
$-0.15 |
| 2014-12-31 |
$-0.14 |
| 2014-09-30 |
$0.51 |
| 2014-06-30 |
$-0.16 |
| 2014-03-31 |
$-0.15 |
| 2013-12-31 |
$-0.13 |
| 2013-09-30 |
$-0.17 |
| 2013-06-30 |
$-0.24 |
| 2013-03-31 |
$-0.22 |
| 2012-12-31 |
$0.02 |
| 2012-09-30 |
$-0.33 |
| 2012-06-30 |
$-0.32 |
| 2012-03-31 |
$-0.39 |
| 2011-12-31 |
$-0.30 |
| 2011-09-30 |
$-0.34 |
| 2011-06-30 |
$1.64 |
| 2011-03-31 |
$-0.69 |
| 2010-12-31 |
$-0.57 |
| 2010-09-30 |
$-0.52 |
| 2010-06-30 |
$-0.47 |
| 2010-03-31 |
$-0.58 |
| 2009-12-31 |
$-0.02 |
| 2009-09-30 |
$-0.41 |
| 2009-06-30 |
$-0.49 |
| 2009-03-31 |
$-0.06 |
